Snoop’s Death Row Records Launches Cannabis Brands
1.2 min readPublished On: January 3rd, 2023By News Team
LOS ANGELES- Snoop Dogg, who now owns Death Row Records, has announced the launch of a new brand of Death Row Cannabis. A legendary label, Death Row Records, has launched a new cannabis the cannabis industry. Last Friday, the Death Row Records instagram account shared a brief animated video announcing the new endeavor – Death Row Cannabis.
According to High Times, Death Row Cannabis will first be available at select Cookies California stores throughout California in Brentwood, San Bernardino, and San Diego on Monday, January 2, 2023, with other locations and more states to follow.
Death Row’s new Cannabis brand’s branding
An Instagram post from artist MylarMen promoted the brand with a 22-second animated clip with a metallic logo and music from Snoop’s longtime collaborator DJ Battlecat. The new logo of the label shows the signature prisoner with his left hand free, holding a joint.
Death Row Cannabis says its offerings will be for craft connoisseurs, with cannabis cultivated by AK, a legendary West Coast grower. AK is best known in the cannabis world for his role alongside former partner WizardTrees in sprouting, selecting, and crafting unique phenotypes of strains including RS11, Studio 54, and Shirazi from exotic cannabis breeder DEO.
The inaugural product of the new brand will be a cannabis flower. Death Row Cannabis will release in-stores next week with details about shop locations upon its drop.
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
The 16th edition of the Benzinga Cannabis Capital Conference, the world's largest gathering of high-impact decision-makers, founders, and investors in the cannabis industry, is set to take place at the Fontainebleau Miami Beach Hotel on ...
"Mighty Flower: How Cannabis Saved My Son," written by Dr. Annabelle Manalo-Morgan, Ph.D., is now available. Published by Forbes Books, the book is a mix of personal memoir and examination of the growth of medicinal ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more